Some drugs may interact with Semaglutide, requiring adjustments to doses or treatment plans
It is a supplier formulation name rather than a single compound, and it is supplied for laboratory research use only
A new oral GLP-1 therapy, orforglipron (Foundayo) by Eli Lilly and Company, has received US FDA approval, marking a major step forward in accessible weight-management solutions and intensifying competition with Novo Nordisk
Some studies indicate that regular coffee consumption may have protective effects
Much of the safety data comes from animal studies, where researchers report on tolerance and effects in those models
GLP-1 and Increased Incidence of Cholesterol Gallstones: What You Need to Know Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide and liraglutide, have transformed the management of type 2 diabetes and obesity